Skip to content

Medical-device intelligence

QFG: Alternate Controller Enabled Insulin Infusion Pump

FDA product code QFG: Alternate Controller Enabled Insulin Infusion Pump. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QFG
FDA device name
Alternate Controller Enabled Insulin Infusion Pump
Device class
2
Regulation number
880.5730
Medical specialty
Clinical Chemistry
Review panel
CH

FDA definition

An alternate controller enabled insulin infusion pump (ACE insulin pump) is a device intended for the infusion of insulin into a patient. The ACE insulin pump may include basal and bolus drug delivery at set or variable rates. ACE insulin pumps are designed to reliably and securely communicate with external devices, such as automated insulin dosing systems, to allow insulin delivery commands to be received, executed, and confirmed. ACE insulin pumps are intended to be used both alone and in conjunction with digitally connected medical devices for the purpose of insulin delivery.
Explore clinical chemistry records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

29 clearance records and 24 recall records in the covered releases, across 9 source company names and 1 product codes. Dated history runs from Sep 20, 2019 to Oct 21, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202501
November 202510
December 202500
January 202612
February 202601
March 202612
April 202610
May 202602
June 202610
July 202603
August 202601
September 202611
October 202610

Product codes represented

Code and FDA device nameClearancesRecalls
QFG · Alternate Controller Enabled Insulin Infusion Pump2924

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

53 matching records
Device / recordCompany in FDA recordSourceSource date
Omnipod 5 ACE Pump (Pod)K203768 · QFGInsulet Corporation510(k)Jan 27, 2022FDA decision date
t:slim X2 Insulin Pump with Interoperable TechnologyK201214 · QFGTandem Diabetes Care, Inc.510(k)Jun 4, 2020FDA decision date
Omnipod DASH Insulin Management System with interoperable technologyK191679 · QFGInsulet Corporation510(k)Sep 20, 2019FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗